IceCure Medical (ICCM) Projected to Post Earnings on Thursday

IceCure Medical (NASDAQ:ICCM) will likely be issuing its quarterly earnings data before the market opens on Thursday, March 27th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $1.07 million for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

IceCure Medical Stock Up 3.2 %

Shares of NASDAQ:ICCM opened at $1.29 on Tuesday. IceCure Medical has a 1-year low of $0.48 and a 1-year high of $1.66. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.67 and a quick ratio of 2.27. The stock has a market cap of $71.60 million, a P/E ratio of -4.45 and a beta of 0.37. The firm has a fifty day moving average price of $1.32 and a 200 day moving average price of $0.98.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reiterated a “buy” rating and set a $2.50 target price on shares of IceCure Medical in a research note on Wednesday, November 27th.

About IceCure Medical

IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology.